How about a $477M biotech IPO amid Hong Kong protests? Henlius will find out
A third month of protests in Hong Kong is not stopping Shanghai Henlius Biotech’s push to get listed on its stock exchange.
The $477 million IPO bid marks the first big test for HKEX’s nascent biotech corner since the city became engulfed in political turmoil over a now withdrawn extradition bill and subsequent police brutality. Bloomberg has previously reported that the company was eyeing as much as $600 million.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.